Literature DB >> 28385633

Impaired expression of GABA transporters in the human Alzheimer's disease hippocampus, subiculum, entorhinal cortex and superior temporal gyrus.

Tessa E Fuhrer1, Thulani H Palpagama1, Henry J Waldvogel1, Beth J L Synek2, Clinton Turner2, Richard L Faull1, Andrea Kwakowsky3.   

Abstract

Gamma-aminobutyric acid (GABA) is the main inhibitory neurotransmitter in the brain and plays an important role in regulating neuronal excitability. GABA reuptake from the synapse is dependent on specific transporters - mainly GAT-1, GAT-3 and BGT-1 (GATs). This study is the first to show alterations in the expression of the GATs in the Alzheimer's disease (AD) hippocampus, entorhinal cortex and superior temporal gyrus. We found a significant increase in BGT-1 expression associated with AD in all layers of the dentate gyrus, in the stratum oriens of the CA2 and CA3 and the superior temporal gyrus. In AD there was a significant decrease in GAT-1 expression in the entorhinal cortex and superior temporal gyrus. We also found a significant decrease in GAT-3 immunoreactivity in the stratum pyramidale of the CA1 and CA3, the subiculum and entorhinal cortex. These observations indicate that the expression of the GATs shows brain-region- and layer-specific alterations in AD, suggesting a complex activation pattern of different GATs during the course of the disease.
Copyright © 2017 IBRO. Published by Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Alzheimer’s disease; GABA; GABA transporters; human brain

Mesh:

Substances:

Year:  2017        PMID: 28385633     DOI: 10.1016/j.neuroscience.2017.03.041

Source DB:  PubMed          Journal:  Neuroscience        ISSN: 0306-4522            Impact factor:   3.590


  19 in total

Review 1.  Nutritional modulation of the intestinal microbiota; future opportunities for the prevention and treatment of neuroimmune and neuroinflammatory disease.

Authors:  Vincent C Lombardi; Kenny L De Meirleir; Krishnamurthy Subramanian; Sam M Nourani; Ruben K Dagda; Shannon L Delaney; András Palotás
Journal:  J Nutr Biochem       Date:  2018-04-19       Impact factor: 6.048

2.  Hippocampal Mossy Fibers Synapses in CA3 Pyramidal Cells Are Altered at an Early Stage in a Mouse Model of Alzheimer's Disease.

Authors:  Silvia Viana da Silva; Pei Zhang; Matthias Georg Haberl; Virginie Labrousse; Noëlle Grosjean; Christophe Blanchet; Andreas Frick; Christophe Mulle
Journal:  J Neurosci       Date:  2019-03-18       Impact factor: 6.167

3.  Triiodothyronine Treatment reverses Depression-Like Behavior in a triple-transgenic animal model of Alzheimer's Disease.

Authors:  Andréa V Maglione; Bruna P P do Nascimento; Miriam O Ribeiro; Talytha J L de Souza; Renata E C da Silva; Monica A Sato; Carlos A A Penatti; Luiz R G Britto; Janaina S de Souza; Rui M B Maciel; Rodrigo Rodrigues da Conceição; Roberto Laureano-Melo; Gisele Giannocco
Journal:  Metab Brain Dis       Date:  2022-08-11       Impact factor: 3.655

4.  Structural basis of GABA reuptake inhibition.

Authors:  Zenia Motiwala; Nanda Gowtham Aduri; Hamidreza Shaye; Gye Won Han; Jordy Homing Lam; Vsevolod Katritch; Vadim Cherezov; Cornelius Gati
Journal:  Nature       Date:  2022-06-08       Impact factor: 69.504

5.  Downregulation of GABA Transporter 3 (GAT3) is Associated with Deficient Oxidative GABA Metabolism in Human Induced Pluripotent Stem Cell-Derived Astrocytes in Alzheimer's Disease.

Authors:  Claudia Salcedo; Antonie Wagner; Jens V Andersen; Kasper Tore Vinten; Helle S Waagepetersen; Arne Schousboe; Kristine K Freude; Blanca I Aldana
Journal:  Neurochem Res       Date:  2021-03-12       Impact factor: 3.996

Review 6.  Influence of glutamate and GABA transport on brain excitatory/inhibitory balance.

Authors:  Sheila Ms Sears; Sandra J Hewett
Journal:  Exp Biol Med (Maywood)       Date:  2021-02-07

7.  Metabolic Profiling of Suprachiasmatic Nucleus Reveals Multifaceted Effects in an Alzheimer's Disease Mouse Model.

Authors:  Muhamed N H Eeza; Rico Singer; Corinna Höfling; Jörg Matysik; Huub J M de Groot; Steffen Roβner; A Alia
Journal:  J Alzheimers Dis       Date:  2021       Impact factor: 4.472

Review 8.  Epileptic Mechanisms Shared by Alzheimer's Disease: Viewed via the Unique Lens of Genetic Epilepsy.

Authors:  Jing-Qiong Kang
Journal:  Int J Mol Sci       Date:  2021-07-01       Impact factor: 5.923

9.  Novel Benzodiazepine-Like Ligands with Various Anxiolytic, Antidepressant, or Pro-Cognitive Profiles.

Authors:  Thomas D Prevot; Guanguan Li; Aleksandra Vidojevic; Keith A Misquitta; Corey Fee; Anja Santrac; Daniel E Knutson; Michael Rajesh Stephen; Revathi Kodali; Nicolas M Zahn; Leggy A Arnold; Petra Scholze; Janet L Fisher; Bojan D Marković; Mounira Banasr; James M Cook; Miroslav Savic; Etienne Sibille
Journal:  Mol Neuropsychiatry       Date:  2019-01-23

10.  Prefrontal GABA Levels Correlate with Memory in Older Adults at High Risk for Alzheimer's Disease.

Authors:  Geetanjali Murari; Darren Ri-Sheng Liang; Aliya Ali; Frankie Chan; Mirjam Mulder-Heijstra; Nicolaas Paul L G Verhoeff; Nathan Herrmann; J Jean Chen; Linda Mah
Journal:  Cereb Cortex Commun       Date:  2020-06-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.